Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study.

[1]  M. Shah,et al.  Phase II study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma. , 1985, Cancer treatment reports.

[2]  J. Wharton,et al.  Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trial. , 1984, Cancer treatment reports.

[3]  W. Grosh,et al.  Phase II study of vinblastine in advanced refractory ovarian carcinoma. , 1983, American Journal of Clinical Oncology.

[4]  D. Alberts,et al.  IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPY , 1980, The Lancet.

[5]  W. T. Beck,et al.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. , 1979, Cancer research.

[6]  D. Alberts,et al.  Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial. , 1979, Cancer treatment reports.

[7]  J. Smith,et al.  Second trial drugs in ovarian cancer. , 1977, Gynecologic oncology.

[8]  J. J. Will,et al.  Vinblastine in Neoplastic Disease Midwest Cooperative Chemotherapy Group , 1963 .

[9]  J. G. Armstrong,et al.  Hodgkin's disease, carcinoma of the breast, and other tumors treated with vinblastine sulfate. , 1962, Cancer chemotherapy reports.

[10]  V. Vaitkevicius,et al.  Cytological and clinical observations during vincaleukoblastine therapy of disseminated cancer , 1962, Cancer.

[11]  W. H. Bond,et al.  Vincaleukoblastine. I. Preliminary clinical studies. , 1960, Cancer research.

[12]  B. Spengler,et al.  Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine. , 1983, Cancer research.